NEW YORK GENOME CENTER INC
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$166,954,755
Other Assets
51%
Property, Plant, & Equipment (net)
26%
Receivables (Non-Related)
14%
Cash & Equivalents
6%
Prepaid Expenses
1%
Inventories
<1%
Related-Party Receivables
0%
Investments
0%
Liabilities in 2024 (Year End)
$123,038,215
Other Liabilities
83%
Deferred Revenue
11%
Payables & Accruals
5%
Notes Payable / Debt (Non-Related)
2%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$12,832,237
$9,810,256
-24%
Receivables (Non-Related)
$26,032,358
$23,861,003
-8%
Related-Party Receivables
-
-
-
Inventories
$1,607,153
$1,429,249
-11%
Prepaid Expenses
$2,491,274
$2,478,585
-1%
Investments
-
-
-
Property, Plant, & Equipment (net)
$46,071,277
$43,485,057
-6%
Other Assets
$95,017,931
$85,890,605
-10%
Total Assets
$184,052,230
$166,954,755
-9%
Liabilities
2023
2024
Change
Payables & Accruals
$7,098,614
$5,863,554
-17%
Grants Payable
-
-
-
Deferred Revenue
$14,803,697
$13,422,281
-9%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$2,660,000
$1,940,000
-27%
Related-Party Payables
-
-
-
Other Liabilities
$113,573,845
$101,812,380
-10%
Total Liabilities
$138,136,156
$123,038,215
-11%
Net assets
2023
2024
Change
Restricted Net Assets
$25,711,149
$29,219,123
+14%
Unrestricted Net Assets
$20,204,925
$14,697,417
-27%
Net assets
2023
2024
Change
Net assets
+$45,916,074
+$43,916,540
-4%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)